Company Announcements

Notice of Interim Results

Source: RNS
RNS Number : 9760Y
Elixirr International PLC
12 September 2022


("Elixirr", the "Company" or the "Group")

Notice of Interim Results

Elixirr International plc (AIM:ELIX), an established, global award-winning challenger consultancy, announces that its interim results for the six months ended 30 June 2022 will be released on 20 September 2022.

For further information, please contact:

Elixirr International plc

Stephen Newton, CEO

Graham Busby, CFO


Public and Investor Relations contacts:

Caroline Pitt




finnCap Ltd (Nominated Adviser & Sole Broker)

Christopher Raggett, Charlie Beeson (Corporate Finance)

Alice Lane, Sunila De Silva (ECM)



+44 (0)20 7220 0500



About Elixirr International plc

Elixirr is an established global award-winning management consultancy, challenging the larger consultancies by delivering innovative and bespoke solutions to a repeat, globally-recognised client base.

Elixirr was founded in 2009, by Stephen Newton, Graham Busby, Ian Ferguson, Andy Curtis and Mark Goodyear, experienced business advisors who identified a market opportunity to provide bespoke, personal services as a 'challenger' to the traditional consultancy businesses in the market. Elixirr guides its clients to overcome challenges such as: future-proofing against technological disruption; development and roll-out of new propositions, products and services; incubating new businesses; navigating a more complex and multinational regulatory environment; and project management and implementation of major change programmes.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.